http://www.medpagetoday.com/Nephrology/Diabetes/32954
don't read if you are feeling some burnout...
this kind of info is really NOT what I want to know thanks Dox! 8)
THE GOOD NEWS....
Tighter control in clinical trials with hemoglobin A1c (HbA1c) targets ranging from 7.1% to less than 6% significantly cut down on micro- and macroalbuminuria compared with conventional glucose control, Steven G. Coca, DO, MS, of Yale and the VA Medical Center in West Haven, Conn., and colleagues found.
BUT.....
.... the intensive strategy had no impact on doubling of serum creatinine level, risk of end-stage renal disease, or death from renal disease, they reported in the May 28 issue of the Archives of Internal Medicine.
don't read if you are feeling some burnout...
this kind of info is really NOT what I want to know thanks Dox! 8)
THE GOOD NEWS....
Tighter control in clinical trials with hemoglobin A1c (HbA1c) targets ranging from 7.1% to less than 6% significantly cut down on micro- and macroalbuminuria compared with conventional glucose control, Steven G. Coca, DO, MS, of Yale and the VA Medical Center in West Haven, Conn., and colleagues found.
BUT.....
.... the intensive strategy had no impact on doubling of serum creatinine level, risk of end-stage renal disease, or death from renal disease, they reported in the May 28 issue of the Archives of Internal Medicine.